汇丰-康方生物(9926HK):买入:一线肺癌HARMONI-6总生存期结果向好,为中国创新药领域关键里程碑-Akeso(9926 HK)Buy:Promising HARMONI-6 OS in 1L lung cancer,a key milestone for China innovative drug sector-20260601【11页】

发表回复

后才能评论